Literature DB >> 28412

On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat.

U M Al-Shabibi, N S Doggett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 28412     DOI： 10.1111/j.2042-7158.1978.tb13316.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  The effects of agents acting at pre- and postsynaptic alpha-adrenoceptors on haloperidol catalepsy [proceedings].

Authors:  J Brown; S L Handley
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

2.  Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

Authors:  P C Waldmeier; R Ortmann; S Bischoff
Journal:  Experientia       Date:  1982-10-15

3.  Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.

Authors:  J J Balsara; N V Nandal; N P Burte; J H Jadhav; A G Chandorkar
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.

Authors:  Mark S Kleven; Marie-Bernadette Assié; Cristina Cosi; Catherine Barret-Grévoz; Adrian Newman-Tancredi
Journal:  Psychopharmacology (Berl)       Date:  2004-09-24       Impact factor: 4.530

5.  The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-29       Impact factor: 3.000

6.  Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?

Authors:  R L Singhal; R B Rastogi; Y D Lapierre
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.